Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
The purpose of the clinical trial (NCT02690558) is to evaluate whether adding pembrolizumab (Keytruda) to the combination of gemcitabine and cisplatin will improve shrinkage of the tumor before having a cystectomy, for people with muscle-invasive bladder cancer (MIBC). ]]> Patients from Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy trial (NCT02690558) with tissue and blood available for processing.]]>
创建时间：
2023-10-19
